BRAND NAME AGILENT OPENLAB CDS AND ECM SOFTWARE MAINTENANCE
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FDA OFFICE OF ACQ GRANT SVCS
Contract Value
Not provided
Codes & Classification
Solicitation Number
75F40126Q00330
NAICS
334516 - Analytical Laboratory Instrument Manufacturing
Classification Code
DA01
Additional Details
Documents2
The Food and Drug Administration (FDA), under the Department of Health and Human Services, has issued a combined synopsis/solicitation for a service contract to provide maintenance for the Agilent OpenLab Chromatography Data System (CDS) and Enterprise Content Management (ECM) software. This procurement is being managed by the FDA Office of Acquisition and Grant Services, with the primary point of contact being Tiffany Hatcher ([email protected], 240-402-1492).
The intended scope of this contract is to ensure the continued operational integrity and reliability of the Agilent OpenLab CDS and ECM software systems currently deployed at the Office of Pharmaceutical Quality Research (OPQR) in North Bethesda, Maryland. OPQR is a laboratory-based office within the Center for Drug Evaluation and Research (CDER) that relies heavily on advanced analytical methods and computer modeling to conduct research focused on evaluating pharmaceutical product and process design, and their impact on product quality.
The Agilent OpenLab CDS and ECM systems are mission-critical tools for OPQR, serving as the primary software platforms for controlling high-performance liquid chromatography (HPLC) systems, as well as for analyzing and securely storing chromatographic data. These systems are integral to the daily research and regulatory activities of the office, supporting both scientific inquiry and compliance with regulatory standards.
The primary objective of this procurement is to secure comprehensive software maintenance services that will ensure the Agilent OpenLab CDS and ECM systems remain up-to-date and fully functional. The contractor will be responsible for providing timely software updates and addressing any reported issues to minimize downtime and maintain the integrity of research operations. The expected deliverables include, but may not be limited to, regular software updates, technical support, troubleshooting, and resolution of software-related problems as they arise.
This opportunity is classified under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing), with a Product Service Code of DA01. There are no set-aside restrictions associated with this procurement, making it open to all qualified vendors. The place of performance is specified as North Bethesda, Maryland, United States.
Interested contractors should review the solicitation documents available on SAM.gov (Opportunity ID: fe2cfe88d9ad44049891c5deba255851) and submit their responses by August 3, 2026. The notice remains active as of the posting date, July 28, 2026, and includes two attachments for further reference.
This procurement represents a critical support function for the FDA’s research and regulatory mission, ensuring that essential laboratory software systems remain robust, secure, and fully operational throughout the contract lifecycle.